StockNews.AI
NDOI
StockNews.AI
179 days

Endo to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

1. Endo to release Q4 and full-year 2024 results on March 11, 2025. 2. Earnings report scheduled pre-market may drive price volatility. 3. Conference call set for 8:00 a.m. ET to discuss financial outcomes.

3m saved
Insight
Article

FAQ

Why Neutral?

Earnings announcements typically trigger volatility; however, without positive or negative details, the overall price impact remains neutral. Past earnings events in the pharmaceutical sector have exhibited similar ambiguity until detailed results are disclosed.

How important is it?

Earnings announcements are crucial events that typically cause significant immediate volatility. With Endo's diversified portfolio and market expectations, this event is likely to impact NDOI's price.

Why Short Term?

Earnings releases often lead to immediate price swings in the near-term. Historical earnings reports from pharma companies have demonstrated short-term market reactions.

Related Companies

MALVERN, Pa., Feb. 21, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it will report fourth quarter and full year 2024 financial results on March 11, 2025, prior to market open. The Company will host a conference call on the same day at 8:00 a.m. ET. The audio webcast may be accessed through the Investor Relations section of the Company's website at investor.endo.com under Events & Presentations. To access the call through a conference line, participants may dial 800-836-8184 (U.S. and Canada toll-free) or 646-357-8785 (outside the U.S.). Participants are advised to join 10 minutes prior to the scheduled start time. A replay of the webcast will be available following the event. About EndoEndo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more at www.endo.com or connect with us on LinkedIn. SOURCE Endo, Inc.

Related News